Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HALOPERIDOL TREATMENT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lipska, BK; Khaing, ZZ; Weickert, CS; Weinberger, DR
      BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

      EUROPEAN JOURNAL OF NEUROSCIENCE
    2. Knott, V; Labelle, A; Jones, B; Mahoney, C
      Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment

      SCHIZOPHRENIA RESEARCH
    3. Roberts, RC
      Effect of chronic olanzapine treatment on striatal synaptic organization

      SYNAPSE
    4. Muriel, MP; Agid, Y; Hirsch, E
      Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease

      MOVEMENT DISORDERS
    5. Joyce, JN
      Dopamine D-3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs

      PHARMACOLOGY & THERAPEUTICS
    6. Sousa, FCF; Gomes, PB; Noronha, EC; Macedo, DS; Vasconcelos, SMM; Fonteles, MMF; Viana, GSB
      Effects of dopaminergic and cholinergic interactions on rat behavior

      LIFE SCIENCES
    7. Freeman, AS; Weddige, FK; Lipinski, JL
      Effect of glucose on antipsychotic drug-induced changes in dopamine neuronal activity

      EUROPEAN JOURNAL OF PHARMACOLOGY
    8. Konradi, C; Heckers, S
      Antipsychotic drugs and neuroplasticity: Insights into the treatment and neurobiology of schizophrenia

      BIOLOGICAL PSYCHIATRY
    9. Lidow, MS; Song, ZM; Castner, SA; Allen, PB; Greengard, P; Goldman-Rakic, PS
      Antipsychotic treatment induces alterations in dendrite- and spine-associated proteins in dopamine-rich areas of the primate cerebral cortex

      BIOLOGICAL PSYCHIATRY
    10. Bertolino, A; Callicott, JH; Mattay, VS; Weidenhammer, KM; Rakow, R; Egan, MF; Weinberger, DR
      The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

      BIOLOGICAL PSYCHIATRY
    11. Bauer, R; Mayr, A; Lederer, W; Needham, PL; Kilpatrick, IC; Fleischhacker, WW; Marksteiner, J
      Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs

      NEUROPSYCHOPHARMACOLOGY
    12. Matson, JL; Bamburg, JW; Mayville, EA; Pinkston, J; Bielecki, J; Kuhn, D; Smalls, Y; Logan, JR
      Psychopharmacology and mental retardation: a 10 year review (1990-1999)

      RESEARCH IN DEVELOPMENTAL DISABILITIES
    13. Eastwood, SL; Burnet, PWJ; Harrison, PJ
      Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain

      SYNAPSE
    14. Kapur, S; Wadenberg, ML; Remington, G
      Are animal studies of antipsychotics appropriately dosed?: Lessons from the bedside to the bench

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    15. Andreassen, OA; Jorgensen, HA
      Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats- Implications for tardive dyskinesia?

      PROGRESS IN NEUROBIOLOGY
    16. Goulet, M; Grondin, R; Morissette, M; Maltais, S; Falardeau, P; Bedard, PJ; Di Paolo, T
      Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    17. Meredith, GE; De Souza, IEJ; Hyde, TM; Tipper, G; Wong, ML; Egan, MF
      Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias

      JOURNAL OF NEUROSCIENCE
    18. Castner, SA; Williams, GV; Goldman-Rakic, PS
      Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation

      SCIENCE
    19. Besret, L; Kendall, AL; Dunnett, SB
      Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease

      JOURNAL OF ANATOMY
    20. Rosoklija, G; Toomayan, G; Ellis, SP; Keilp, J; Mann, JJ; Latov, N; Hays, AP; Dwork, AJ
      Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders - Preliminary findings

      ARCHIVES OF GENERAL PSYCHIATRY
    21. Harrison, PJ
      The neuropathological effects of antipsychotic drugs

      SCHIZOPHRENIA RESEARCH
    22. Atkins, JB; Chlan-Fourney, J; Nye, HE; Hiroi, N; Carlezon, WA; Nestler, EJ
      Region-specific induction of Delta FosB by repeated administration of typical versus atypical antipsychotic drugs

      SYNAPSE
    23. Gueudet, C; Santucci, V; Soubrie, P; Le Fur, G
      Blockade of neurokinin(3) receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs

      SYNAPSE
    24. Fines, RE; Brady, WJ; Martin, ML
      Acute laryngeal dystonia related to neuroleptic agents

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    25. Zhang-Wong, J; Zipursky, RB; Beiser, M; Bean, G
      Optimal haloperidol dosage in first-episode psychosis

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    26. Nagamoto, HT; Adler, LE; McRae, KA; Huettl, P; Cawthra, E; Gerhardt, G; Hea, R; Griffith, J
      Auditory P50 in schizophrenics on clozapine: Improved gating parallels clinical improvement and changes in plasma 3-methoxy-4-hydroxyphenylglycol

      NEUROPSYCHOBIOLOGY
    27. Ase, AR; Amdiss, F; Hebert, C; Huang, N; van Gelder, NM; Reader, TA
      Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin(1A) receptors

      JOURNAL OF NEURAL TRANSMISSION
    28. Shen, RY; Hannigan, JH; Kapatos, G
      Prenatal ethanol reduces the activity of adult midbrain dopamine neurons

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    29. Saria, A
      The tachykinin NK1 receptor in the brain: pharmacology and putative functions

      EUROPEAN JOURNAL OF PHARMACOLOGY
    30. Harrison, PJ
      The neuropathology of schizophrenia - A critical review of the data and their interpretation

      BRAIN
    31. Selemon, LD; Lidow, MS; Goldman-Rakic, PS
      Increased volume and glial density in primate prefrontal cortex associatedwith chronic antipsychotic drug exposure

      BIOLOGICAL PSYCHIATRY
    32. Silva, RH; Felicio, LF; Frussa, R
      Ganglioside GM1 attenuates scopolamine-induced amnesia in rats and mice

      PSYCHOPHARMACOLOGY
    33. MCCOY L; COX C; RICHFIELD EK
      ANTIPSYCHOTIC DRUG REGULATION OF AMPA RECEPTOR AFFINITY STATES AND GLUR1, GLUR2 SPLICE VARIANT EXPRESSION

      Synapse
    34. DAI M; TEPPER JM
      DO SILENT DOPAMINERGIC-NEURONS EXIST IN RAT SUBSTANTIA-NIGRA IN-VIVO

      Neuroscience
    35. APARICIOLEGARZA MI; DAVIS B; HUTSON PH; REYNOLDS GP
      INCREASED DENSITY OF GLUTAMATE N-METHYL-D-ASPARTATE RECEPTORS IN PUTAMEN FROM SCHIZOPHRENIC-PATIENTS/

      Neuroscience letters
    36. ARNT J
      PHARMACOLOGICAL DIFFERENTIATION OF CLASSICAL AND NOVEL ANTIPSYCHOTICS

      International clinical psychopharmacology
    37. Ohara, K; Nagai, M; Tani, K; Nakamura, Y; Ino, A; Ohara, K
      Functional polymorphism of -141C Ins/Del in the dopamine D-2 receptor genepromoter and schizophrenia

      PSYCHIATRY RESEARCH
    38. SOKOLOV BP
      EXPRESSION OF NMDAR1, GLUR1, GLUR7, AND KA1 GLUTAMATE-RECEPTOR MESSENGER-RNAS IS DECREASED IN FRONTAL-CORTEX OF NEUROLEPTIC-FREE SCHIZOPHRENICS - EVIDENCE ON REVERSIBLE UP-REGULATION BY TYPICAL NEUROLEPTICS

      Journal of neurochemistry
    39. WILLIAMS JH; WELLMAN NA; GEANEY DP; COWEN PJ; FELDON J; RAWLINS JNP
      REDUCED LATENT INHIBITION IN PEOPLE WITH SCHIZOPHRENIA - AN EFFECT OFPSYCHOSIS OR OF ITS TREATMENT

      British Journal of Psychiatry
    40. WALTERS VL; TOGNOLINI RZ; RUEDA HM; RUEDA RM; TORRES RG
      NEW STRATEGIES FOR OLD PROBLEMS - TARDIVE-DYSKINESIA (TD) - REVIEW AND REPORT ON SEVERE TD CASES TREATED WITH CLOZAPINE, WITH 12, 8 AND 5 YEARS OF VIDEO FOLLOW-UP

      Schizophrenia research
    41. LUCIANA M; COLLINS PF
      DOPAMINERGIC MODULATION OF WORKING-MEMORY FOR SPATIAL BUT NOT OBJECT CUES IN NORMAL HUMANS

      Journal of cognitive neuroscience
    42. KOSTEN TA
      ENHANCED NEUROBEHAVIORAL EFFECTS OF COCAINE WITH CHRONIC NEUROLEPTIC EXPOSURE IN RATS

      Schizophrenia bulletin
    43. BRAUN AR; LARUELLE M; MOURADIAN MM
      INTERACTIONS BETWEEN D1 AND D2 DOPAMINE-RECEPTOR FAMILY AGONISTS AND ANTAGONISTS - THE EFFECTS OF CHRONIC EXPOSURE ON BEHAVIOR AND RECEPTOR-BINDING IN RATS AND THEIR CLINICAL IMPLICATIONS

      Journal of neural transmission
    44. VITAL MABF; FRUSSA R; PALERMONETO J
      EFFECTS OF MONOSIALOGANGLIOSIDE ON A NEW MODEL OF TARDIVE-DYSKINESIA

      Progress in neuro-psychopharmacology & biological psychiatry
    45. KNABLE MB; WEINBERGER DR
      DOPAMINE, THE PREFRONTAL CORTEX AND SCHIZOPHRENIA

      JOURNAL OF PSYCHOPHARMACOLOGY
    46. ARNT J; SKARSFELDT T; HYTTEL J
      DIFFERENTIATION OF CLASSICAL AND NOVEL ANTIPSYCHOTICS USING ANIMAL-MODELS

      International clinical psychopharmacology
    47. GRACE AA; BUNNEY BS; MOORE H; TODD CL
      DOPAMINE-CELL DEPOLARIZATION BLOCK AS A MODEL FOR THE THERAPEUTIC ACTIONS OF ANTIPSYCHOTIC-DRUGS

      Trends in neurosciences
    48. DSOUZA U; MCGUFFIN P; BUCKLAND PR
      ANTIPSYCHOTIC REGULATION OF DOPAMINE D-1, D-2 AND D-3 RECEPTOR MESSENGER-RNA

      Neuropharmacology
    49. QUEIROZ CMT; FRUSSA R
      EFFECTS OF BUSPIRONE ON DOPAMINERGIC SUPERSENSITIVITY

      Life sciences
    50. JOYCE JN; GOLDSMITH SG; GUREVICH EV
      LIMBIC CIRCUITS AND MONOAMINE RECEPTORS - DISSECTING THE EFFECTS OF ANTIPSYCHOTICS FROM DISEASE PROCESSES

      Journal of Psychiatric Research
    51. LIDOW MS; ELSWORTH JD; GOLDMANRAKIC PS
      DOWN-REGULATION OF THE D1 AND D5 DOPAMINE-RECEPTORS IN THE PRIMATE PREFRONTAL CORTEX BY CHRONIC TREATMENT WITH ANTIPSYCHOTIC-DRUGS

      The Journal of pharmacology and experimental therapeutics
    52. BERGERON R; DEMONTIGNY C; DEBONNEL G
      EFFECT OF SHORT-TERM AND LONG-TERM TREATMENTS WITH SIGMA-LIGANDS ON THE N-METHYL-D-ASPARTATE RESPONSE IN THE CA(3) REGION OF THE RAT DORSALHIPPOCAMPUS

      British Journal of Pharmacology
    53. RITTER LM; MEADORWOODRUFF JH
      ANTIPSYCHOTIC REGULATION OF HIPPOCAMPAL DOPAMINE-RECEPTOR MESSENGER-RNA EXPRESSION

      Biological psychiatry
    54. JONESHUMBLE SA; DURCAN MJ; LYERLY D; NORTON RM; TANG FLM; RUSSELL AV; WATSON MJ; GENGO PJ; MORGAN PF; WANG CM; COOPER BR; COX RF
      PRECLINICAL NEUROCHEMICAL AND ELECTROPHYSIOLOGICAL PROFILE OF 1192U90, A POTENTIAL ANTIPSYCHOTIC

      Neuropsychopharmacology
    55. BEUGER M; VANKAMMEN DP; KELLEY ME; YAO J
      DOPAMINE TURNOVER IN SCHIZOPHRENIA BEFORE AND AFTER HALOPERIDOL WITHDRAWAL - CSF, PLASMA, AND URINE STUDIES

      Neuropsychopharmacology
    56. MINABE Y; EMORI K; TOOR A; STUTZMANN GE; ASHBY CR
      THE EFFECT OF THE ACUTE AND CHRONIC ADMINISTRATION OF CP-96,345, A SELECTIVE NEUROKININ(1), RECEPTOR ANTAGONIST, ON MIDBRAIN DOPAMINE NEURONS IN THE RAT - A SINGLE-UNIT, EXTRACELLULAR RECORDING STUDY

      Synapse
    57. DZIEDZICKAWASYLEWSKA M; MACKOWIAK M; FIJAR K; WEDZONY K
      ADAPTIVE-CHANGES IN THE RAT DOPAMINERGIC TRANSMISSION FOLLOWING REPEATED LITHIUM ADMINISTRATION

      Journal of neural transmission
    58. EGAN MF; CHRAPUSTA S; KAROUM F; LIPSKA BK; WYATT RJ
      EFFECTS OF CHRONIC NEUROLEPTIC TREATMENT ON DOPAMINE RELEASE - INSIGHTS FROM STUDIES USING 3-METHOXYTYRAMINE

      Journal of neural transmission
    59. GANDOLFI O; DALLOLIO R
      MODULATORY ROLE OF DOPAMINE ON EXCITATORY AMINO-ACID RECEPTORS

      Progress in neuro-psychopharmacology & biological psychiatry
    60. WHITE FJ
      SYNAPTIC REGULATION OF MESOCORTICOLIMBIC DOPAMINE NEURONS

      Annual review of neuroscience
    61. DZIEDZICKAWASYLEWSKA M; WEDZONY K
      THE EFFECT OF PROLONGED ADMINISTRATION OF LITHIUM ON THE LEVEL OF DOPAMINE D-2 RECEPTOR MESSENGER-RNA IN THE RAT STRIATUM AND NUCLEUS-ACCUMBENS

      Acta Neurobiologiae Experimentalis
    62. MORISSETTE M; GOULET M; CALON F; FALARDEAU P; BLANCHET PJ; BEDARD PJ; DIPAOLO T
      CHANGES OF D-1 AND D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IN THE BRAINS OF MONKEYS LESIONED WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRECTION WITH CHRONIC ADMINISTRATION OF L-3,4-DIHYDROXYPHENYLALANINE

      Molecular pharmacology
    63. BRODIE MS; BUNNEY EB
      SEROTONIN POTENTIATES DOPAMINE-INHIBITION OF VENTRAL TEGMENTAL AREA NEURONS IN-VITRO

      Journal of neurophysiology
    64. LAVIN A; GRACE AA
      PHYSIOLOGICAL-PROPERTIES OF RAT VENTRAL PALLIDAL NEURONS RECORDED INTRACELLULARLY IN-VIVO

      Journal of neurophysiology
    65. MELE A; CASTELLANO C; FELICI A; CABIB S; CACCIA S; OLIVERIO A
      DOPAMINE-N-METHYL-D-ASPARTATE INTERACTIONS IN THE MODULATION OF LOCOMOTOR-ACTIVITY AND MEMORY CONSOLIDATION IN MICE

      European journal of pharmacology
    66. HURLEY MJ; STUBBS CM; JENNER P; MARSDEN CD
      EFFECT OF CHRONIC TREATMENT WITH TYPICAL AND ATYPICAL NEUROLEPTICS ONTHE EXPRESSION OF DOPAMINE D-2 AND D-3 RECEPTORS IN RAT-BRAIN

      Psychopharmacology
    67. MELE A; CASTELLANO C; CESTARI V; OLIVERIO A
      INTERACTION BETWEEN THE NMDA COMPETITIVE ANTAGONIST CPP AND THE DOPAMINERGIC SYSTEM IN ONE-TRIAL INHIBITORY AVOIDANCE IN C57BL 6 MICE/

      Neurobiology of learning and memory
    68. FRIEDHOFF AJ; CARR KD; UYSAL S; SCHWEITZER J
      REPEATED INESCAPABLE STRESS PRODUCES A NEUROLEPTIC-LIKE EFFECT ON THECONDITIONED AVOIDANCE-RESPONSE

      Neuropsychopharmacology
    69. JABER M; CADOR M; DUMARTIN B; NORMAND E; STINUS L; BLOCH B
      ACUTE AND CHRONIC AMPHETAMINE TREATMENTS DIFFERENTLY REGULATE NEUROPEPTIDE MESSENGER-RNA LEVELS AND FOS IMMUNOREACTIVITY IN RAT STRIATAL NEURONS

      Neuroscience
    70. BROG JS; ZAHM DS
      MORPHOLOGY AND FOS IMMUNOREACTIVITY REVEAL 2 SUBPOPULATIONS OF STRIATAL NEUROTENSIN NEURONS FOLLOWING ACUTE 6-HYDROXYDOPAMINE LESIONS AND RESERPINE ADMINISTRATION

      Neuroscience
    71. VERNA A; SCHAMEL A; LEMOINE C; BLOCH B
      LOCALIZATION OF DOPAMINE D2 RECEPTOR MESSENGER-RNA IN GLOMUS CELLS OFTHE RABBIT CAROTID-BODY BY IN-SITU HYBRIDIZATION

      Journal of neurocytology
    72. HARRINGTON KA; AUGOOD SJ; FAULL RLM; MCKENNA PJ; EMSON PC
      DOPAMINE D-1 RECEPTOR, D-2 RECEPTOR, PROENKEPHALIN-A AND SUBSTANCE-P GENE-EXPRESSION IN THE CAUDATE-NUCLEUS OF CONTROL AND SCHIZOPHRENIC TISSUE - A QUANTITATIVE CELLULAR IN-SITU HYBRIDIZATION STUDY

      Molecular brain research
    73. RICHTAND NM; KELSOE JR; SEGAL DS; KUCZENSKI R
      REGIONAL QUANTIFICATION OF D1, D2, AND D3 DOPAMINE-RECEPTOR MESSENGER-RNA IN RAT-BRAIN USING A RIBONUCLEASE PROTECTION ASSAY

      Molecular brain research
    74. JABER M; NORMAND E; BLOCH B
      EFFECT OF RESERPINE TREATMENT ON ENKEPHALIN MESSENGER-RNA LEVEL IN THE RAT STRIATUM - AN IN-SITU HYBRIDIZATION STUDY

      Molecular brain research
    75. BRAMBILLA F; BRUNETTA M; PEIRONE A; PERNA G; SACERDOTE P; MANFREDI B; PANERAI AE
      T-LYMPHOCYTE CHOLECYSTOKININ-8 AND BETA-ENDORPHIN CONCENTRATIONS IN EATING DISORDERS .1. ANOREXIA-NERVOSA

      Psychiatry research
    76. KIYATKIN EA
      FUNCTIONAL-SIGNIFICANCE OF MESOLIMBIC DOPAMINE

      Neuroscience and biobehavioral reviews
    77. LEVESQUE D; MARTRES MP; DIAZ J; GRIFFON N; LAMMERS CH; SOKOLOFF P; SCHWARTZ JC
      A PARADOXICAL REGULATION OF THE DOPAMINE D-3 RECEPTOR EXPRESSION SUGGESTS THE INVOLVEMENT OF AN ANTEROGRADE FACTOR FROM DOPAMINE NEURONS

      Proceedings of the National Academy of Sciences of the United Statesof America
    78. DOLAN M; BOYD C; SHETTY G
      NEUROLEPTIC-INDUCED SUDDEN-DEATH - A CASE-REPORT AND CRITICAL-REVIEW

      Medicine, Science and the Law
    79. SZEWCZAK MR; CORBETT R; RUSH DK; WILMOT CA; CONWAY PG; STRUPCZEWSKI JT; CORNFELDT M
      THE PHARMACOLOGICAL PROFILE OF ILOPERIDONE, A NOVEL ATYPICAL ANTIPSYCHOTIC AGENT

      The Journal of pharmacology and experimental therapeutics
    80. PARSONS B; TOGASAKI DM; KASSIR S; PRZEDBORSKI S
      NEUROLEPTICS UP-REGULATE ADENOSINE A(2A) RECEPTORS IN RAT STRIATUM - IMPLICATIONS FOR THE MECHANISM AND THE TREATMENT OF TARDIVE-DYSKINESIA

      Journal of neurochemistry
    81. LEDUC PA; MITTLEMAN G
      SCHIZOPHRENIA AND PSYCHOSTIMULANT ABUSE - A REVIEW AND REANALYSIS OF CLINICAL-EVIDENCE

      Psychopharmacology
    82. CHRONWALL BM; DICKERSON DS; HUERTER BS; SIBLEY DR; MILLINGTON WR
      REGULATION OF HETEROGENEITY IN D-2 DOPAMINE-RECEPTOR GENE-EXPRESSION AMONG INDIVIDUAL MELANOTROPES IN THE RAT PITUITARY INTERMEDIATE LOBE

      Molecular and cellular neurosciences
    83. TODOROVA A; DIMPFEL W
      MULTIUNIT ACTIVITY FROM THE A9 AND A10 AREAS IN RATS FOLLOWING CHRONIC TREATMENT WITH DIFFERENT NEUROLEPTIC DRUGS

      European neuropsychopharmacology
    84. QIN ZH; WEISS B
      DOPAMINE-RECEPTOR BLOCKADE INCREASES DOPAMINE D-2 RECEPTOR AND GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNAS IN MOUSE SUBSTANTIA-NIGRA

      European journal of pharmacology. Molecular pharmacology section
    85. YAO JK; VANKAMMEN DP; WELKER JA
      RED-BLOOD-CELL MEMBRANE DYNAMICS IN SCHIZOPHRENIA .2. FATTY-ACID COMPOSITION

      Schizophrenia research
    86. YAO JK; VANKAMMEN DP
      RED-BLOOD-CELL MEMBRANE DYNAMICS IN SCHIZOPHRENIA .1. MEMBRANE FLUIDITY

      Schizophrenia research
    87. SEE RE; CHAPMAN MA
      THE CONSEQUENCES OF LONG-TERM ANTIPSYCHOTIC DRUG ADMINISTRATION ON BASAL GANGLIA NEURONAL FUNCTION IN LABORATORY-ANIMALS

      Critical reviews in neurobiology
    88. QIN ZH; ZHOU LW; WEISS B
      D-2 DOPAMINE-RECEPTOR MESSENGER-RNA IS ALTERED TO A GREATER EXTENT BYBLOCKADE OF GLUTAMATE RECEPTORS THAN BY BLOCKADE OF DOPAMINE-RECEPTORS

      Neuroscience
    89. ANDIA I; ZUMARRAGA M; RETUERTO F; ZAMALLOA I; DAVILA R
      CHRONIC NEUROLEPTIC TREATMENT DOES NOT SUPPRESS THE DYNAMIC CHARACTERISTICS OF THE DOPAMINERGIC RECEPTOR D2 SYSTEM

      Progress in neuro-psychopharmacology & biological psychiatry
    90. LITWIN LC; GOLDSTEIN JM
      EFFECTS OF NEUROTENSIN ON MIDBRAIN DOPAMINE NEURONAL-ACTIVITY

      Drug development research
    91. ASHBY CR; MINABE Y; TOOR A; FISHKIN LD; GRANOFF MI; WANG RY
      EFFECT PRODUCED BY ACUTE AND CHRONIC ADMINISTRATION OF THE SELECTIVE 5-HT3 RECEPTOR ANTAGONIST BRL-46470 ON THE NUMBER OF SPONTANEOUSLY ACTIVE MIDBRAIN DOPAMINE CELLS IN THE RAT

      Drug development research
    92. YAMAMOTO BK; COOPERMAN MA
      DIFFERENTIAL-EFFECTS OF CHRONIC ANTIPSYCHOTIC DRUG-TREATMENT ON EXTRACELLULAR GLUTAMATE AND DOPAMINE CONCENTRATIONS

      The Journal of neuroscience
    93. KING DJ
      THE USE OF HIGH-DOSES OF NEUROLEPTICS - THE CURRENT SITUATION

      International clinical psychopharmacology
    94. SEILER W; WETZEL H; HILLERT A; SCHOLLNHAMMER G; BENKERT O; HIEMKE C
      PLASMA-LEVELS OF BENPERIDOL, PROLACTIN, AND HOMOVANILLIC-ACID AFTER INTRAVENOUS VERSUS 2 DIFFERENT KINDS OF ORAL APPLICATION OF THE NEUROLEPTIC IN SCHIZOPHRENIC-PATIENTS

      Experimental and clinical endocrinology
    95. CHEN JF; ALOYO VJ; QIN ZH; WEISS B
      IRREVERSIBLE BLOCKADE OF D-2 DOPAMINE-RECEPTORS BY FLUPHENAZINE-N-MUSTARD INCREASES D-2 DOPAMINE-RECEPTOR MESSENGER-RNA AND PROENKEPHALIN MESSENGER-RNA AND DECREASES D-1 DOPAMINE-RECEPTOR MESSENGER-RNA AND MU-OPIOID AND DELTA-OPIOID RECEPTORS IN RAT STRIATUM

      Neurochemistry international
    96. GARDNER EL; CHEN JP; PAREDESW
      CLOZAPINE PRODUCES POTENT ANTIDOPAMINERGIC EFFECTS ANATOMICALLY SPECIFIC TO THE MESOLIMBIC SYSTEM

      The Journal of clinical psychiatry
    97. DRUCKER GE; RITZMANN RF; WICHLINSKI LJ; ENGH K; GORDON JH; FIELDS JZ
      PREVENTION AND REVERSAL OF DOPAMINE-RECEPTOR SUPERSENSITIVITY BY CYCLO(LEUCYL-GLYCYL) (CLG) - BIPHASIC DOSE-RESPONSE CURVES

      Pharmacology, biochemistry and behavior
    98. ZHANG HL; KIYATKIN EA; STEIN EA
      BEHAVIORAL AND PHARMACOLOGICAL MODULATION OF VENTRAL TEGMENTAL DENDRITIC DOPAMINE RELEASE

      Brain research
    99. GALDERISI S; MAJ M; MUCCI A; BUCCI P; KEMALI D
      QEEG ALPHA1 CHANGES AFTER A SINGLE-DOSE OF HIGH-POTENCY NEUROLEPTICS AS A PREDICTOR OF SHORT-TERM RESPONSE TO TREATMENT IN SCHIZOPHRENIC-PATIENTS

      Biological psychiatry
    100. KOREEN AR; LIEBERMAN J; ALVIR J; MAYERHOFF D; LOEBEL A; CHAKOS M; AMIN F; COOPER T
      PLASMA HOMOVANILLIC-ACID LEVELS IN FIRST-EPISODE SCHIZOPHRENIA - PSYCHOPATHOLOGY AND TREATMENT RESPONSE

      Archives of general psychiatry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 17/02/20 alle ore 08:03:55